Eintrag weiter verarbeiten

Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of...

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Alzheimer's & Dementia
Personen und Körperschaften: Nicolas, Gaël, Schramm, Catherine, Miguel, Laetitia, Lacour, Morgane, Rousseau, Stéphane, Wallon, David, Charbonnier, Camille, Zarea, Aline, Campion, Dominique, Rovelet‐Lecrux, Anne, Lecourtois, Magalie
In: Alzheimer's & Dementia, 16, 2020, S3
Format: E-Article
Sprache: Englisch
veröffentlicht:
Wiley
Schlagwörter:
author_facet Nicolas, Gaël
Schramm, Catherine
Miguel, Laetitia
Lacour, Morgane
Rousseau, Stéphane
Wallon, David
Charbonnier, Camille
Zarea, Aline
Campion, Dominique
Rovelet‐Lecrux, Anne
Lecourtois, Magalie
Nicolas, Gaël
Schramm, Catherine
Miguel, Laetitia
Lacour, Morgane
Rousseau, Stéphane
Wallon, David
Charbonnier, Camille
Zarea, Aline
Campion, Dominique
Rovelet‐Lecrux, Anne
Lecourtois, Magalie
author Nicolas, Gaël
Schramm, Catherine
Miguel, Laetitia
Lacour, Morgane
Rousseau, Stéphane
Wallon, David
Charbonnier, Camille
Zarea, Aline
Campion, Dominique
Rovelet‐Lecrux, Anne
Lecourtois, Magalie
spellingShingle Nicolas, Gaël
Schramm, Catherine
Miguel, Laetitia
Lacour, Morgane
Rousseau, Stéphane
Wallon, David
Charbonnier, Camille
Zarea, Aline
Campion, Dominique
Rovelet‐Lecrux, Anne
Lecourtois, Magalie
Alzheimer's & Dementia
Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Geriatrics and Gerontology
Neurology (clinical)
Developmental Neuroscience
Health Policy
Epidemiology
author_sort nicolas, gaël
spelling Nicolas, Gaël Schramm, Catherine Miguel, Laetitia Lacour, Morgane Rousseau, Stéphane Wallon, David Charbonnier, Camille Zarea, Aline Campion, Dominique Rovelet‐Lecrux, Anne Lecourtois, Magalie 1552-5260 1552-5279 Wiley Psychiatry and Mental health Cellular and Molecular Neuroscience Geriatrics and Gerontology Neurology (clinical) Developmental Neuroscience Health Policy Epidemiology http://dx.doi.org/10.1002/alz.044561 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p> <jats:italic>SORL1</jats:italic> rare (allele frequency &lt;1%) loss‐of‐function (LOF) and missense predicted damaging (Mis3) variants have first been identified in early‐onset Alzheimer disease (EOAD, onset before 66 years) patients with a positive family history. However, segregation data in families are still missing to assess the actual pattern of inheritance. Since then, we and others have shown an increased burden of <jats:italic>SORL1</jats:italic> rare LOF and Mis3 variants in EOAD patients, whatever the family history, and in late onset AD patients, with a lower effect size. In addition, although the interpretation of the biological effect of LOF variants is rather straightforward, no formal evidence of a functional effect of Mis3 variants can be inferred from bioinformatics predictions only.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>We gathered data from French families with a rare LOF or Mis3 variant and developed a cellular model to assess the role of SORL1 missense variants.</jats:p></jats:sec><jats:sec><jats:title>Result</jats:title><jats:p>We studied 20 families with a LOF variant (mean age at onset (AAO) in probands, 55.4 years, range: [48‐65]). Seventeen showed a positive family history. Mean AAO in affected relatives was 66.3 (range: [50‐80]). One patient carried two LOF compound heterozygous variants. DNA was available in 18 relatives: 5/6 affected relatives carried the familial variant (AAO = [61‐78]) while 3/12 unaffected were also carriers, aged 42, 71 and 95, respectively. Strikingly, 57% affected carriers were APOE4+ including one homozygous, who was also a carrier of a LOF rare ABCA7 risk variant.</jats:p><jats:p>We developed a functional assay using CRISPR/Cas9 introduction of variants in iPSCs. We succeeded in introducing a homozygous LOF variant showing increased levels of Aβ in the supernatant. We are now inducing neuronal differentiation and introducing missense variants to better sort missense variants for penetrance studies and understand mechanisms. Interestingly, in one family with a Mis3 variant associated with increased Aβ secretion, the proband was APOE4+ and carried a LOF rare ABCA7 risk variant. Additional families and variants are currently being studied.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our data support incomplete penetrance and oligogenic determinism in <jats:italic>SORL1</jats:italic> families, making genetic counseling difficult. The development of cellular models will help us understand how and which missense variants result in reduced SORL1 functions.</jats:p></jats:sec> Genetics/genetic factors of Alzheimer's disease Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease Alzheimer's & Dementia
doi_str_mv 10.1002/alz.044561
facet_avail Online
finc_class_facet Medizin
Psychologie
Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hbHouMDQ0NTYx
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hbHouMDQ0NTYx
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
issn 1552-5260
1552-5279
issn_str_mv 1552-5260
1552-5279
language English
mega_collection Wiley (CrossRef)
match_str nicolas2020assessmentofsorl1rarevariantssegregationinalzheimerdiseasefamiliesandinvitromodelssuggestsdiversepenetranceandoligogenicinheritancegeneticsgeneticfactorsofalzheimersdiseasegeneticsgeneticfactorsofalzheimersdisease
publishDateSort 2020
publisher Wiley
recordtype ai
record_format ai
series Alzheimer's & Dementia
source_id 49
title_sub Genetics/genetic factors of Alzheimer's disease
title Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_unstemmed Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_full Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_fullStr Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_full_unstemmed Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_short Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_sort assessment of sorl1 rare variants segregation in alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : genetics/genetic factors of alzheimer's disease
topic Psychiatry and Mental health
Cellular and Molecular Neuroscience
Geriatrics and Gerontology
Neurology (clinical)
Developmental Neuroscience
Health Policy
Epidemiology
url http://dx.doi.org/10.1002/alz.044561
publishDate 2020
physical
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p> <jats:italic>SORL1</jats:italic> rare (allele frequency &lt;1%) loss‐of‐function (LOF) and missense predicted damaging (Mis3) variants have first been identified in early‐onset Alzheimer disease (EOAD, onset before 66 years) patients with a positive family history. However, segregation data in families are still missing to assess the actual pattern of inheritance. Since then, we and others have shown an increased burden of <jats:italic>SORL1</jats:italic> rare LOF and Mis3 variants in EOAD patients, whatever the family history, and in late onset AD patients, with a lower effect size. In addition, although the interpretation of the biological effect of LOF variants is rather straightforward, no formal evidence of a functional effect of Mis3 variants can be inferred from bioinformatics predictions only.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>We gathered data from French families with a rare LOF or Mis3 variant and developed a cellular model to assess the role of SORL1 missense variants.</jats:p></jats:sec><jats:sec><jats:title>Result</jats:title><jats:p>We studied 20 families with a LOF variant (mean age at onset (AAO) in probands, 55.4 years, range: [48‐65]). Seventeen showed a positive family history. Mean AAO in affected relatives was 66.3 (range: [50‐80]). One patient carried two LOF compound heterozygous variants. DNA was available in 18 relatives: 5/6 affected relatives carried the familial variant (AAO = [61‐78]) while 3/12 unaffected were also carriers, aged 42, 71 and 95, respectively. Strikingly, 57% affected carriers were APOE4+ including one homozygous, who was also a carrier of a LOF rare ABCA7 risk variant.</jats:p><jats:p>We developed a functional assay using CRISPR/Cas9 introduction of variants in iPSCs. We succeeded in introducing a homozygous LOF variant showing increased levels of Aβ in the supernatant. We are now inducing neuronal differentiation and introducing missense variants to better sort missense variants for penetrance studies and understand mechanisms. Interestingly, in one family with a Mis3 variant associated with increased Aβ secretion, the proband was APOE4+ and carried a LOF rare ABCA7 risk variant. Additional families and variants are currently being studied.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our data support incomplete penetrance and oligogenic determinism in <jats:italic>SORL1</jats:italic> families, making genetic counseling difficult. The development of cellular models will help us understand how and which missense variants result in reduced SORL1 functions.</jats:p></jats:sec>
container_issue S3
container_start_page 0
container_title Alzheimer's & Dementia
container_volume 16
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792333318615728145
geogr_code not assigned
last_indexed 2024-03-01T14:10:51.991Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Assessment+of+SORL1+rare+variants+segregation+in+Alzheimer+disease+families+and+in+vitro+models+suggests+diverse+penetrance+and+oligogenic+inheritance+%3A+Genetics%2Fgenetic+factors+of+Alzheimer%27s+disease&rft.date=2020-12-01&genre=article&issn=1552-5279&volume=16&issue=S3&jtitle=Alzheimer%27s+%26+Dementia&atitle=Assessment+of+SORL1+rare+variants+segregation+in+Alzheimer+disease+families+and+in+vitro+models+suggests+diverse+penetrance+and+oligogenic+inheritance+%3A+Genetics%2Fgenetic+factors+of+Alzheimer%27s+disease&aulast=Lecourtois&aufirst=Magalie&rft_id=info%3Adoi%2F10.1002%2Falz.044561&rft.language%5B0%5D=eng
SOLR
_version_ 1792333318615728145
author Nicolas, Gaël, Schramm, Catherine, Miguel, Laetitia, Lacour, Morgane, Rousseau, Stéphane, Wallon, David, Charbonnier, Camille, Zarea, Aline, Campion, Dominique, Rovelet‐Lecrux, Anne, Lecourtois, Magalie
author_facet Nicolas, Gaël, Schramm, Catherine, Miguel, Laetitia, Lacour, Morgane, Rousseau, Stéphane, Wallon, David, Charbonnier, Camille, Zarea, Aline, Campion, Dominique, Rovelet‐Lecrux, Anne, Lecourtois, Magalie, Nicolas, Gaël, Schramm, Catherine, Miguel, Laetitia, Lacour, Morgane, Rousseau, Stéphane, Wallon, David, Charbonnier, Camille, Zarea, Aline, Campion, Dominique, Rovelet‐Lecrux, Anne, Lecourtois, Magalie
author_sort nicolas, gaël
container_issue S3
container_start_page 0
container_title Alzheimer's & Dementia
container_volume 16
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p> <jats:italic>SORL1</jats:italic> rare (allele frequency &lt;1%) loss‐of‐function (LOF) and missense predicted damaging (Mis3) variants have first been identified in early‐onset Alzheimer disease (EOAD, onset before 66 years) patients with a positive family history. However, segregation data in families are still missing to assess the actual pattern of inheritance. Since then, we and others have shown an increased burden of <jats:italic>SORL1</jats:italic> rare LOF and Mis3 variants in EOAD patients, whatever the family history, and in late onset AD patients, with a lower effect size. In addition, although the interpretation of the biological effect of LOF variants is rather straightforward, no formal evidence of a functional effect of Mis3 variants can be inferred from bioinformatics predictions only.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>We gathered data from French families with a rare LOF or Mis3 variant and developed a cellular model to assess the role of SORL1 missense variants.</jats:p></jats:sec><jats:sec><jats:title>Result</jats:title><jats:p>We studied 20 families with a LOF variant (mean age at onset (AAO) in probands, 55.4 years, range: [48‐65]). Seventeen showed a positive family history. Mean AAO in affected relatives was 66.3 (range: [50‐80]). One patient carried two LOF compound heterozygous variants. DNA was available in 18 relatives: 5/6 affected relatives carried the familial variant (AAO = [61‐78]) while 3/12 unaffected were also carriers, aged 42, 71 and 95, respectively. Strikingly, 57% affected carriers were APOE4+ including one homozygous, who was also a carrier of a LOF rare ABCA7 risk variant.</jats:p><jats:p>We developed a functional assay using CRISPR/Cas9 introduction of variants in iPSCs. We succeeded in introducing a homozygous LOF variant showing increased levels of Aβ in the supernatant. We are now inducing neuronal differentiation and introducing missense variants to better sort missense variants for penetrance studies and understand mechanisms. Interestingly, in one family with a Mis3 variant associated with increased Aβ secretion, the proband was APOE4+ and carried a LOF rare ABCA7 risk variant. Additional families and variants are currently being studied.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our data support incomplete penetrance and oligogenic determinism in <jats:italic>SORL1</jats:italic> families, making genetic counseling difficult. The development of cellular models will help us understand how and which missense variants result in reduced SORL1 functions.</jats:p></jats:sec>
doi_str_mv 10.1002/alz.044561
facet_avail Online
finc_class_facet Medizin, Psychologie, Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hbHouMDQ0NTYx
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161
issn 1552-5260, 1552-5279
issn_str_mv 1552-5260, 1552-5279
language English
last_indexed 2024-03-01T14:10:51.991Z
match_str nicolas2020assessmentofsorl1rarevariantssegregationinalzheimerdiseasefamiliesandinvitromodelssuggestsdiversepenetranceandoligogenicinheritancegeneticsgeneticfactorsofalzheimersdiseasegeneticsgeneticfactorsofalzheimersdisease
mega_collection Wiley (CrossRef)
physical
publishDate 2020
publishDateSort 2020
publisher Wiley
record_format ai
recordtype ai
series Alzheimer's & Dementia
source_id 49
spelling Nicolas, Gaël Schramm, Catherine Miguel, Laetitia Lacour, Morgane Rousseau, Stéphane Wallon, David Charbonnier, Camille Zarea, Aline Campion, Dominique Rovelet‐Lecrux, Anne Lecourtois, Magalie 1552-5260 1552-5279 Wiley Psychiatry and Mental health Cellular and Molecular Neuroscience Geriatrics and Gerontology Neurology (clinical) Developmental Neuroscience Health Policy Epidemiology http://dx.doi.org/10.1002/alz.044561 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p> <jats:italic>SORL1</jats:italic> rare (allele frequency &lt;1%) loss‐of‐function (LOF) and missense predicted damaging (Mis3) variants have first been identified in early‐onset Alzheimer disease (EOAD, onset before 66 years) patients with a positive family history. However, segregation data in families are still missing to assess the actual pattern of inheritance. Since then, we and others have shown an increased burden of <jats:italic>SORL1</jats:italic> rare LOF and Mis3 variants in EOAD patients, whatever the family history, and in late onset AD patients, with a lower effect size. In addition, although the interpretation of the biological effect of LOF variants is rather straightforward, no formal evidence of a functional effect of Mis3 variants can be inferred from bioinformatics predictions only.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>We gathered data from French families with a rare LOF or Mis3 variant and developed a cellular model to assess the role of SORL1 missense variants.</jats:p></jats:sec><jats:sec><jats:title>Result</jats:title><jats:p>We studied 20 families with a LOF variant (mean age at onset (AAO) in probands, 55.4 years, range: [48‐65]). Seventeen showed a positive family history. Mean AAO in affected relatives was 66.3 (range: [50‐80]). One patient carried two LOF compound heterozygous variants. DNA was available in 18 relatives: 5/6 affected relatives carried the familial variant (AAO = [61‐78]) while 3/12 unaffected were also carriers, aged 42, 71 and 95, respectively. Strikingly, 57% affected carriers were APOE4+ including one homozygous, who was also a carrier of a LOF rare ABCA7 risk variant.</jats:p><jats:p>We developed a functional assay using CRISPR/Cas9 introduction of variants in iPSCs. We succeeded in introducing a homozygous LOF variant showing increased levels of Aβ in the supernatant. We are now inducing neuronal differentiation and introducing missense variants to better sort missense variants for penetrance studies and understand mechanisms. Interestingly, in one family with a Mis3 variant associated with increased Aβ secretion, the proband was APOE4+ and carried a LOF rare ABCA7 risk variant. Additional families and variants are currently being studied.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our data support incomplete penetrance and oligogenic determinism in <jats:italic>SORL1</jats:italic> families, making genetic counseling difficult. The development of cellular models will help us understand how and which missense variants result in reduced SORL1 functions.</jats:p></jats:sec> Genetics/genetic factors of Alzheimer's disease Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease Alzheimer's & Dementia
spellingShingle Nicolas, Gaël, Schramm, Catherine, Miguel, Laetitia, Lacour, Morgane, Rousseau, Stéphane, Wallon, David, Charbonnier, Camille, Zarea, Aline, Campion, Dominique, Rovelet‐Lecrux, Anne, Lecourtois, Magalie, Alzheimer's & Dementia, Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Geriatrics and Gerontology, Neurology (clinical), Developmental Neuroscience, Health Policy, Epidemiology
title Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_full Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_fullStr Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_full_unstemmed Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_short Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
title_sort assessment of sorl1 rare variants segregation in alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : genetics/genetic factors of alzheimer's disease
title_sub Genetics/genetic factors of Alzheimer's disease
title_unstemmed Assessment of SORL1 rare variants segregation in Alzheimer disease families and in vitro models suggests diverse penetrance and oligogenic inheritance : Genetics/genetic factors of Alzheimer's disease
topic Psychiatry and Mental health, Cellular and Molecular Neuroscience, Geriatrics and Gerontology, Neurology (clinical), Developmental Neuroscience, Health Policy, Epidemiology
url http://dx.doi.org/10.1002/alz.044561